Clinical Core
Clinical Core
批准号:
10406868
负责人:
HILLEL GROSSMAN
金额:
$135.88万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-01 至 2025-02-28
关键词:
AffectAgeAlzheimer&aposs DiseaseAssessment toolAttentionAutopsyBiologicalBiological MarkersBrainClinicalClinical DataClinical ResearchClinical TrialsCognitionCognition DisordersCognitiveCollaborationsCommunitiesCultural DiversityDNADataData CollectionData SetDementiaDevelopmentDiagnosticDiseaseElderlyEnsureEthnic OriginEvaluationFosteringFrequenciesGeneticGenotypeGoalsHealth systemHeterogeneityImaging technologyImpaired cognitionImpairmentIndividualIndustryInstitutionIntervention StudiesLigandsMethodsMinority GroupsMinority ParticipationNeuropsychologyNormal RangeObservational StudyParticipantPatientsPhenotypePhysiciansPopulationPositron-Emission TomographyPostdoctoral FellowProceduresProtocols documentationRaceRecording of previous eventsRegistriesResearchResearch PersonnelResearch SubjectsResearch TechnicsResourcesRiskRoleSamplingServicesSideSpecific qualifier valueSpecimenStandardizationTechniquesTissuesTrainingUnderrepresented PopulationsUnited States National Institutes of HealthWorkbiomarker developmentclinical biomarkersclinical materialclinical phenotypeclinical translationcognitive testingcohortcooperative studydata sharingdesigndisorder riskdoctoral studentethnic diversityfollow-upgenome-widehigh standardimaging biomarkerinnovationinstrumentinterestmild cognitive impairmentneuroimagingneuropathologynormal agingnoveloutreachpatient populationpre-clinicalprogramsrecruitresiliencescreeningtreatment response
中文摘要
西奈山ADRC(佐野):临床核心(核心B)-研究总结
临床核心提供认知障碍患者的临床和生物学特征方面的专业知识。
丧失和痴呆以及识别未受损老年人的能力。这些专业知识被用来招聘
并维持一组不同年龄、临床表现、教育程度、种族和
种族这个特征鲜明的队列支持广泛的痴呆和认知研究
在ISMMS、西奈山卫生系统(MSHS)和国家倡议(如
国家阿尔茨海默病协调中心(NACC),全基因组阿尔茨海默病研究(GWAS),阿尔茨海默病
疾病合作研究(ADCS)和阿尔茨海默病神经影像学倡议(ADNI)。的作用
核心是开发和实施临床程序,并收集高标准的生物标志物
老年人的特征,包括正常、前驱和受影响受试者的各个阶段
“准备好研究”的人群临床核心为研究提供受试者、组织和数据,
与疾病的临床表现、病程、治疗反应相关的临床研究专业知识,
和招聘的可行性,以帮助指导设计和实施研究中心内和广泛
在MSHS中。在中心内,临床核心提供了研究的基本要素:受试者和
参与生物标志物和遗传学核心的临床表征;
脑捐赠和其他标本分发给神经病理学核心;临床和教育
与ORE和REC核心的项目和学员互动的专业知识。核心创新在于
开发评估工具;将评估应用于新人群;调整新成像
将技术应用于临床“真实的世界”;以及对新的、研究不足的或重新利用的化合物进行临床试验。
该中心在向痴呆症研究中代表性不足的群体进行外展方面有着丰富而成功的历史,
本申请书已加入条文,以延续这项规定。该中心积极培训年轻的调查人员,
支持来自其他领域的研究人员,他们希望在他们的临床人群中研究认知。
英文摘要
Mount Sinai ADRC (Sano): Clinical Core (Core B) – Research Summary
The Clinical Core provides expertise in the clinical and biological characterization of individuals with cognitive
loss and dementia and the ability to identify non-impaired older individuals. This expertise is utilized to recruit
and maintain a cohort of participants of varying ages, clinical presentations, educational attainment, races and
ethnicities. This well-characterized cohort supports a broad array of dementia and cognitive research
conducted within the ISMMS, the Mount Sinai Health System (MSHS,) and national initiatives such as the
National Alzheimer's Coordinating Center (NACC), the Genome Wide Alzheimer's Study (GWAS), Alzheimer's
Disease Cooperative Studies (ADCS), and the Alzheimer's Disease Neuroimaging Initiative (ADNI). The role of
the core is to develop and implement clinical procedures and collect biomarkers for the high standard
characterization of elders spanning the spectrum of normal, prodromal, and various stages of affected subjects
into “research-ready” cohorts. The Clinical Core provides subjects, tissue, and data for studies as well as
clinical research expertise related to clinical manifestations of disease, disease course, treatment responses,
and recruitment feasibility to help guide the design and implementation of studies within the Center and broadly
within the MSHS. Within the Center, the Clinical Core provides the essentials for research: the subjects and
their clinical characterization to participate in the Biomarker and Genetics Cores; the clinical characterization of
brain donations and other specimens disseminated to the Neuropathology Core; clinical and educational
expertise to interact with the projects and trainees of the ORE and REC cores. The Core innovates in the
development of assessment tools; application of assessments to new populations; adaptation of new imaging
technologies into the clinical `real world'; and clinical trials of novel, under-studied or repurposed compounds.
The Core has a rich and successful history of outreach to groups underrepresented in dementia research and
provisions to continue this are built into this application. The Core is active in training young investigators and
supporting investigators from other fields who wish to study cognition in their clinical populations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical Core
-
批准号:10614003
-
项目类别:
-
资助金额:$100.75万
-
财政年份:2020
-
负责人:HILLEL GROSSMAN
-
依托单位:
DEVELOPMENT OF D-PINITOL IN THE TREATMENT OF ALZHEIMER'S DISEASE
-
批准号:7953697
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2009
-
负责人:HILLEL GROSSMAN
-
依托单位:
DEVELOPMENT OF D-PINITOL IN THE TREATMENT OF ALZHEIMER'S DISEASE
-
批准号:7718187
-
项目类别:
-
资助金额:$10.1万
-
财政年份:2008
-
负责人:HILLEL GROSSMAN
-
依托单位:
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE
-
批准号:7718146
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2008
-
负责人:HILLEL GROSSMAN
-
依托单位:
ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE
-
批准号:7605329
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2007
-
负责人:HILLEL GROSSMAN
-
依托单位:
Pilot studies of the nutritional supplement d-pinitol in Alzheimer's Disease
-
批准号:7148117
-
项目类别:
-
资助金额:$33.9万
-
财政年份:2006
-
负责人:HILLEL GROSSMAN
-
依托单位:
Pilot studies of the nutritional supplement NIC5-15 in Alzheimers Disease
-
批准号:7295704
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2006
-
负责人:HILLEL GROSSMAN
-
依托单位:
Pilot studies of the nutritional supplement d-pinitol in Alzheimer's Disease
-
批准号:7447321
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2006
-
负责人:HILLEL GROSSMAN
-
依托单位:
A TRIAL OF AN INSULIN-SENSITIVITY ENHANCING AGENT TO IMPROVE COGNITIVE OUTCOM
-
批准号:7202479
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2005
-
负责人:HILLEL GROSSMAN
-
依托单位:
A Trial of an Insulin-Sensitivity Enhancing Agent to Improve Cognitive Outcom...
-
批准号:7044857
-
项目类别:
-
资助金额:$0.68万
-
财政年份:2004
-
负责人:HILLEL GROSSMAN
-
依托单位:
Core B - Clinical
-
批准号:9054746
-
项目类别:
-
资助金额:$34.13万
-
财政年份:--
-
负责人:HILLEL GROSSMAN
-
依托单位:
Core B - Clinical
-
批准号:8849210
-
项目类别:
-
资助金额:$34.06万
-
财政年份:--
-
负责人:HILLEL GROSSMAN
-
依托单位:
Clinical Core
-
批准号:9922013
-
项目类别:
-
资助金额:$81.64万
-
财政年份:--
-
负责人:HILLEL GROSSMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: